Treatment of autoimmune diseases
US7820161B1 · kind B1 · utility
121Cited by
71References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 4, 2000 |
| Grant date | Oct 26, 2010 |
| Priority date | — |
| Expiry date | May 4, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed of treating rheumatoid arthritis in a human comprising administering to the human more than one intravenous dose of a therapeutically effective amount of rituximab and administering methotrexate to the human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.